Stay updated with breaking news from Trifecta Valve. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The U.S. Food and Drug Administration (FDA) is providing an update to the February 27, 2023 Letter to Health Care Providers about the potential risk of early structural valve deterioration (SVD) with Abbott Trifecta valves, including the Trifecta Valve and Trifecta Valve with Glide Technology (GT)
Health news and commentary from around the Web gathered by <em>MedPage Today</em> staff
The action follows an FDA letter to professionals in February warning of a potential for structural failure.
The Food and Drug Administration has issued a safety alert regarding the potential risk of early structural valve deterioration with Abbott Trifecta valves.
Some evidence suggests early structural valve deterioration is more common with these valves than others on the market.